Boston Scientific Corporation is an American medical device manufacturer. The company offers solutions for the following medical specialties: electrophysiology, gastroenterology, vascular surgery, gynecology, interventional cardiology, interventional radiology, female pelvic medicine, neurological surgery, orthopedic surgery, pulmology, pain medicine, structural heart, urology.
P/E ratio for Boston Scientific (BSX)
P/E ratio as of July 2025 (TTM): 75.6
According to Boston Scientific's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 75.6014. At the end of 2024 the company had a P/E ratio of 70.9.
P/E ratio history for Boston Scientific from 2001 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 70.9 | 31.21% |
| 2023 | 54.0 | -47.45% |
| 2022 | 103 | 67.01% |
| 2021 | 61.6 | -120.55% |
| 2020 | -300 | -2339.26% |
| 2019 | 13.4 | -54.19% |
| 2018 | 29.2 | -90.57% |
| 2017 | 310 | 272.48% |
| 2016 | 83.2 | -181.55% |
| 2015 | -102 | -256.32% |
| 2014 | 65.3 | -145.46% |
| 2013 | -144 | 6889.85% |
| 2012 | -2.05 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | 11.2 | -85.23% | 🇺🇸 USA |
 Stryker Corporation SYK | 52.3 | -30.87% | 🇺🇸 USA |
 Merit Medical MMSI | 44.7 | -40.86% | 🇺🇸 USA |
 Medtronic MDT | 27.2 | -64.03% | 🇮🇪 Ireland |
 Teleflex TFX | 36.1 | -52.30% | 🇺🇸 USA |
 AngioDynamics ANGO | -9.53 | -112.61% | 🇺🇸 USA |
 CONMED CNMD | 13.0 | -82.76% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.